Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

213
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
213
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

229
The pathophysiology of pneumonia involves the following steps:
229
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

182
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
182
Pneumonia IV: Management01:28

Pneumonia IV: Management

305
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
305
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

213
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
213
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

806
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
806

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Hospitalisation and healthcare burden of respiratory syncytial virus in adults aged 50 years and older in France, 2015-2022.

Infectious diseases (London, England)·2026
Same author

Long-term prognosis of patients surviving progressive multifocal leukoencephalopathy.

Brain : a journal of neurology·2026
Same author

Pregnant Women COVID-19 immunisation in 2026: evidence, uncertainty and priorities.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Respiratory syncytial virus in adults aged ≥ 50 years in France: a database and time-series modelling analysis (2014-2020).

Infection·2026
Same author

Correction: Pneumococcal vaccination at 65 years and vaccination coverage in at-risk adults: A retrospective population-based study in France.

PloS one·2026
Same author

RSV vaccination in immunocompromised adults.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

相关实验视频

Updated: Jun 12, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.0K

[非典型的细菌性肺炎]

Romaric Larcher1, Paul Loubet1

  • 1Service des maladies infectieuses et tropicales, hôpital Carémeau, CHU de Nîmes, Nîmes, France.

La Revue du praticien
|June 6, 2025
PubMed
概括

非典型的细菌性肺炎呈现非特异性症状,使诊断和治疗复杂化. 早期考虑和具体的测试对于有效的抗生素管理至关重要,如宏化物.

科学领域:

  • 传染性疾病 传染性疾病
  • 肺部病理学 肺部病理学
  • 微生物学 微生物学

背景情况:

  • 非典型的细菌性肺炎是由多种病原体引起的,包括Mycoplasma pneumoniae和Legionella pneumophila.
  • 这些感染具有非特异性的临床,生物和放射性特征,难以与典型的肺炎区分.
  • 病原体通常被标准的微生物学方法遗漏,并且对β-乳酸菌抗生素表现出耐药性.

研究的目的:

  • 突出非典型细菌性肺炎的诊断和治疗复杂性.
  • 强调在肺炎管理中考虑非典型病原体的重要性.
  • 概述适当的抗生素策略和诊断确认方法.

主要方法:

  • 对非典型细菌性肺炎的临床表现,诊断挑战和治疗方法的审查.
  • 讨论诸如Mycoplasma pneumoniae,Chlamydia pneumoniae,Legionella pneumophila,Chlamydia psittaci,Coxiella burnetii和Francisella tularensis之类的病原体. 这些病原体包括:
  • 强调特定诊断测试的作用,如PCR,尿抗原测试和血清学.

主要成果:

  • 非典型的细菌性肺炎往往模仿典型的肺炎,使初步评估复杂化.
关键词:
肺炎, 细菌性肺炎

更多相关视频

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.6K
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

22.7K

相关实验视频

Last Updated: Jun 12, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.0K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.6K
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

22.7K
  • 标准的微生物学技术经常无法检测引起的非典型病原体.
  • 有效的治疗依赖于特定的抗生素 (宏类,四环素,诺) 和有针对性的诊断确认.
  • 结论:

    • 临床医生必须保持高的怀疑指数不典型的细菌性肺炎由于非特异性的呈现.
    • 使用专门测试进行快速准确的诊断对于适当的治疗干预至关重要.
    • 量身定制的抗生素选择和诊断确认显著改善了非典型肺炎病例患者的治疗结果.